Literature DB >> 11127047

[Clinical applications of single photon emission tomography in neuromedicine. 1. Neuro-oncology, epilepsy, movement disorders, cerebrovascular disease].

P Bartenstein1, F Grünwald, T Kuwert, K Tatsch, O Sabri, O Benkert, R Fahlbusch, G Gründer, K Herzholz, C Weiller.   

Abstract

Single photon emission tomography is, because of its availability and the relatively low costs, the functional imaging modality currently most widely used for clinical applications in the brain. Beside the application of radiopharmaceuticals for the assessment of regional cerebral blood flow there is an increasing clinical use of more selective SPECT-radiopharmaceuticals, like amino acid analogs or receptor ligands. This article gives in his first part a critical review of the clinical applications of SPECT in neuro-oncology, epilepsy, basal ganglia disorders and cerebrovascular disease.

Entities:  

Mesh:

Year:  2000        PMID: 11127047

Source DB:  PubMed          Journal:  Nuklearmedizin        ISSN: 0029-5566            Impact factor:   1.379


  2 in total

1.  Robust, fully automatic delineation of the head contour by stereotactical normalization for attenuation correction according to Chang in dopamine transporter scintigraphy.

Authors:  Catharina Lange; Jens Kurth; Anita Seese; Sarah Schwarzenböck; Karen Steinhoff; Bert Umland-Seidler; Bernd J Krause; Winfried Brenner; Osama Sabri; Swen Hesse; Ralph Buchert
Journal:  Eur Radiol       Date:  2015-02-26       Impact factor: 5.315

2.  EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2.

Authors:  Jacques Darcourt; Jan Booij; Klaus Tatsch; Andrea Varrone; Thierry Vander Borght; Ozlem L Kapucu; Kjell Någren; Flavio Nobili; Zuzana Walker; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02       Impact factor: 9.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.